Literature DB >> 10399071

Varicella-zoster virus immune evasion.

A Abendroth1, A Arvin.   

Abstract

CD4+ and CD8+ T cells play dual roles in varicella-zoster virus (VZV) pathogenesis. The first role is to deliver the virus to cutaneous sites during primary VZV infection, permitting replication at these sites and the successful transmission of the virus to other susceptible individuals. The second contribution of T cells is to provide the critical antigen-specific adaptive immunity needed to stop viral replication and maintain VZV latency in sensory ganglia. The equilibrium between VZV and the host can be predicted to be served by immune evasion mechanisms in at least two important ways, including the facilitation of cell-associated viremia during primary VZV infection and silent persistence in dorsal root ganglia. Interference with antigen presentation by MHC class I downregulation may be expected to play a role in both circumstances. Transient interference with MHC class II expression in varicella skin lesions should facilitate local replication and transmission. In addition, when VZV reactivates, the capacity of viral gene products to block the upregulation of MHC class II expression triggered by interferon-gamma should permit a sufficient period of viral replication to cause the lesions of herpes zoster, despite the presence of VZV-specific T cells, and to allow transmission of the virus to susceptible individuals. Although the effort is at an early stage compared to studies of other viral pathogens, identifying the VZV gene products that exert these effects and their mechanisms of interference has the potential to reveal novel aspects of MHC class I and class II antigen processing and presentation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10399071     DOI: 10.1111/j.1600-065x.1999.tb01289.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  19 in total

1.  Varicella-zoster virus productively infects mature dendritic cells and alters their immune function.

Authors:  Gavin Morrow; Barry Slobedman; Anthony L Cunningham; Allison Abendroth
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 2.  Memory CD8 T-cell differentiation during viral infection.

Authors:  E John Wherry; Rafi Ahmed
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

3.  Herpes viruses hedge their bets.

Authors:  Michael P H Stumpf; Zoe Laidlaw; Vincent A A Jansen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-30       Impact factor: 11.205

4.  Modulation of major histocompatibility class II protein expression by varicella-zoster virus.

Authors:  A Abendroth; B Slobedman; E Lee; E Mellins; M Wallace; A M Arvin
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Varicella-zoster virus infection of human dendritic cells and transmission to T cells: implications for virus dissemination in the host.

Authors:  A Abendroth; G Morrow; A L Cunningham; B Slobedman
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus.

Authors:  J G Smith; X Liu; R M Kaufhold; J Clair; M J Caulfield
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

Review 7.  Varicella zoster virus immune evasion strategies.

Authors:  Allison Abendroth; Paul R Kinchington; Barry Slobedman
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

8.  Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor.

Authors:  Zhen Zhang; Anca Selariu; Charles Warden; Grace Huang; Ying Huang; Oluleke Zaccheus; Tong Cheng; Ningshao Xia; Hua Zhu
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

9.  Characterization of varicella-zoster virus gene 21 and 29 proteins in infected cells.

Authors:  Randall J Cohrs; Jeanne Wischer; Carrie Essman; Donald H Gilden
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  A highly efficient protocol of generating and analyzing VZV ORF deletion mutants based on a newly developed luciferase VZV BAC system.

Authors:  Zhen Zhang; Ying Huang; Hua Zhu
Journal:  J Virol Methods       Date:  2008-01-22       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.